[Form 4] CLOROX CO /DE/ Insider Trading Activity

Rhea-AI Filing Summary

Luc Bellet, EVP and Chief Financial Officer of The Clorox Company (CLX), reported an open-market purchase of 7,368 shares of Clorox common stock on 09/16/2025 at a reported price of $124.85 per share. After the purchase, the filing shows Mr. Bellet beneficially owned 19,546 shares. The Form 4 was signed by an attorney-in-fact on 09/18/2025.

The filing also discloses restricted stock units that will vest in four equal installments on October 5, 2026, October 5, 2027, October 5, 2028, and October 5, 2029. No derivative transactions, dispositions, or additional cash- or price-related terms beyond the reported purchase price are included in the document.

Positive

• Insider purchase reported: CFO acquired 7,368 shares at $124.85, which can signal management confidence.
• Clear RSU schedule: Restricted stock units vest in four equal installments on Oct 5, 2026, Oct 5, 2027, Oct 5, 2028, and Oct 5, 2029.

Negative

• None.

Insights

Financial Analyst

TL;DR: CFO purchased 7,368 shares at $124.85, increasing beneficial ownership to 19,546 shares; transaction is a straightforward insider buy.

The purchase is a clear open-market acquisition by a senior executive and is reported in accordance with Section 16 filing requirements. The size of the trade (7,368 shares) and the resulting total ownership (19,546 shares) are modest relative to S&P 500 company insider holdings but indicate an executive-level purchase at the market price reported. The filing includes a standard RSU vesting schedule over four annual installments, which is compensation-related rather than a market transaction. No sales, option exercises, or other material changes to compensation or control are disclosed.

Corporate Governance Expert

TL;DR: Filing shows routine reporting of an insider purchase and standard RSU vesting schedule; no governance red flags present.

The Form 4 documents compliant disclosure of an officer's equity acquisition and the vesting terms for restricted stock units. The use of an attorney-in-fact to file the form is an administrative detail and is acceptable when properly authorized. There is no indication of related-party transactions, accelerated vesting, or other governance concerns within this filing. The disclosure is concise and limited to the transaction and vesting schedule provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Bellet Luc

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CA 94612-1888

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP - Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/16/2025		A(1)		7,368	A	$124.85	19,546	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2026, 2027, 2028, and 2029.

Remarks:

ex24bellet.txt

	By Jinho Joo, Attorney-in-Fact	09/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did CLX insider Luc Bellet report on Form 4?

The Form 4 reports an open-market purchase of 7,368 shares of Clorox common stock on 09/16/2025 at a price of $124.85 per share.

How many Clorox shares does Luc Bellet beneficially own after the transaction?

Following the reported purchase, the filing shows Luc Bellet beneficially owned 19,546 shares.

Does the filing include any derivative transactions or sales by the reporting person?

No. The filing lists a non-derivative acquisition only and does not report any sales, option exercises, or derivative transactions.

What is the vesting schedule for the restricted stock units disclosed in the Form 4?

The restricted stock units vest in four equal installments on October 5 of 2026, 2027, 2028, and 2029.

Who signed the Form 4 filing and when was it filed?

The Form 4 was executed by an attorney-in-fact, Jinho Joo, and dated 09/18/2025.